Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001851971 | SCV002232741 | pathogenic | Hereditary hemochromatosis | 2024-03-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg105*) in the TFR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TFR2 are known to be pathogenic (PMID: 23600741, 26029709). This variant is present in population databases (rs80338878, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with hemochromatosis (PMID: 15147384). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 21375). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000020548 | SCV003811531 | likely pathogenic | Hemochromatosis type 3 | 2022-01-17 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000020548 | SCV004203680 | pathogenic | Hemochromatosis type 3 | 2023-11-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000020548 | SCV000041015 | not provided | Hemochromatosis type 3 | no assertion provided | literature only |